Fine-tuning the treatment toolbox of immune thrombocytopenia: fostamatinib as a second-line therapy

被引：7
作者：
Kapur, Rick [1 ,2 ]
机构：
[1] Sanquin Res, Dept Expt Immunohematol, Amsterdam, Netherlands
[2] Univ Amsterdam, Amsterdam UMC, Landsteiner Lab, Amsterdam, Netherlands
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2020年 / 190卷 / 06期
关键词：
D O I：
10.1111/bjh.16958
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：817 / 818
页数：2
相关论文
共 17 条
  • [1] Boccia R, 2020, THROMBOCYTOPENIA ITP
  • [2] R406, an orally available spleen tyrosine kinase inhibitor blocks Fc receptor signaling and reduces immune complex-mediated inflammation
    Braselmann, Sylvia
    Taylor, Vanessa
    Zhao, Haoran
    Wang, Su
    Sylvain, Catherine
    Baluom, Muhammad
    Qu, Kunbin
    Herlaar, Ellen
    Lau, Angela
    Young, Chi
    Wong, Brian R.
    Lovell, Scott
    Sun, Thomas
    Park, Gary
    Argade, Ankush
    Jurcevic, Stipo
    Pine, Polly
    Singh, Rajinder
    Grossbard, Elliott B.
    Payan, Donald G.
    Masuda, Esteban S.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 319 (03) : 998 - 1008
  • [3] Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials
    Bussel, James
    Arnold, Donald M.
    Grossbard, Elliot
    Mayer, Jiri
    Trelinski, Jacek
    Homenda, Wojciech
    Hellmann, Andrzej
    Windyga, Jerzy
    Sivcheva, Liliya
    Khalafallah, Alhossain A.
    Zaja, Francesco
    Cooper, Nichola
    Markovtsov, Vadim
    Zayed, Hany
    Duliege, Anne-Marie
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (07) : 921 - 930
  • [4] Long-term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program
    Bussel, James B.
    Arnold, Donald M.
    Boxer, Michael A.
    Cooper, Nichola
    Mayer, Jiri
    Zayed, Hany
    Tong, Sandra
    Duliege, Anne-Marie
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (05) : 546 - 553
  • [5] Getting Syk: spleen tyrosine kinase as a therapeutic target
    Geahlen, Robert L.
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2014, 35 (08) : 414 - 422
  • [6] HARRINGTON WJ, 1951, J LAB CLIN MED, V38, P1
  • [7] Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia
    Li, June
    van der Wal, Dianne E.
    Zhu, Guangheng
    Xu, Miao
    Yougbare, Issaka
    Ma, Li
    Vadasz, Brian
    Carrim, Naadiya
    Grozovsky, Renata
    Ruan, Min
    Zhu, Lingyan
    Zeng, Qingshu
    Tao, Lili
    Zhai, Zhi-min
    Peng, Jun
    Hou, Ming
    Leytin, Valery
    Freedman, John
    Hoffmeister, Karin M.
    Ni, Heyu
    [J]. NATURE COMMUNICATIONS, 2015, 6
  • [8] MARINI I, 2019, HAEMATOLOGICA
  • [9] Cellular immune dysfunction in immune thrombocytopenia (ITP)
    McKenzie, Christopher G. J.
    Guo, Li
    Freedman, John
    Semple, John W.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (01) : 10 - 23
  • [10] American Society of Hematology 2019 guidelines for immune thrombocytopenia
    Neunert, Cindy
    Terrell, Deirdra R.
    Arnold, Donald M.
    Buchanan, George
    Cines, Douglas B.
    Cooper, Nichola
    Cuker, Adam
    Despotovic, Jenny M.
    George, James N.
    Grace, Rachael F.
    Kuehne, Thomas
    Kuter, David J.
    Lim, Wendy
    McCrae, Keith R.
    Pruitt, Barbara
    Shimanek, Hayley
    Vesely, Sara K.
    [J]. BLOOD ADVANCES, 2019, 3 (23) : 3829 - 3866
12